Serena Li
Analyst
Wells Fargo
Equibles does not estimate personal net worth.
About Serena Li
Serena Li is recorded as Analyst at Wells Fargo. Serena Li has spoken on 1 earnings call across 1 company, most recently for Biomarin Pharmaceutical Inc on May 1, 2025. The companies whose calls Serena Li spoke on are classified in the Healthcare sector.
Serena Li on recent calls
“I wanted to ask a question about BMN 351. In terms of the muscle dystrophin data to expect in the second half. Is that 10% just different levels the only goal that should inform the future course of action for this molecule, or would you be looking at a bar for other parameters as well?”
Affiliation history
-
Wells Fargo
Analyst
Transcript header (unverified)
Current